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Abstract
A population of cows with excess androstenedione (A4; High A4) in follicular ﬂuid, with follicular arrest, granulosa cell dysfunction, and a 17%
reduction in calving rate was previously identiﬁed. We hypothesized that excess A4 in the ovarian microenvironment caused the follicular arrest
in High A4 cows and that vascular endothelial growth factor A would rescue the High A4 phenotype. In trial 1, prior to culture, High A4 ovarian
cortex (n = 9) had greater numbers of early stage follicles (primordial) and fewer later-stage follicles compared to controls (n = 11). Culture for
7 days did not relieve this follicular arrest; instead, High A4 ovarian cortex had increased indicators of inﬂammation, anti-Mullerian hormone,
and A4 secretion compared to controls. In trial 2, we tested if vascular endothelial growth factor A (VEGFA) angiogenic (165) and antiangiogenic
(VEGFA165b) isoforms could rescue the High A4 phenotype. High A4 (n = 5) and control (n = 5) ovarian cortex was cultured with (1) PBS, (2)
VEGFA165 (50 ng/mL), (3) VEGFA165b (50 ng/mL), or (4) VEGFA165+VEGFA165b (50 ng/mL each) for 7 days. Follicular progression increased
with VEGFA165 in High A4 cows with greater early primary, primary, and secondary follicles than controls. Similar to trial 1, High A4 ovarian
cortex secreted greater concentrations of A4 and other steroids and had greater indicators of inﬂammation compared to controls. However,
VEGFA165 rescued steroidogenesis, oxidative stress, and ﬁbrosis. Both VEGFA isoforms reduced speciﬁc pro-inﬂammatory cytokines in High
A4 cows to control levels. Thus, VEGFA165 may be a potential therapeutic to restore the ovarian steroidogenic microenvironment to promote
folliculogenesis.
Summary sentence VEGFA165 angiogenic isoform can rescue High A4 steroid excess, inﬂammation, and follicular arrest and may be a potential
therapeutic for anovulatory disorders.

Graphical Abstract
Ovarian cortex cultures from High A4 cows secrete increased A4 and other steroid hormones, which may contribute to increased anti-Mullerian
hormone, pro-inﬂammatory cytokines, ﬁbrosis, oxidative stress, follicular arrest, persistent follicles, and anovulation. The VEGFA165 treatment
rescued steroidogenesis, oxidative stress, and ﬁbrosis. The VEGFA165 and VEGFA165b both reduced IL-13, INFα, and INFα secretion in High
A4 cows to control levels. Thus, VEGFA165 may be a potential therapeutic to restore the ovarian steroidogenic microenvironment and may
promote folliculogenesis, resulting in ovulation.
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Introduction
Anovulation is a major cause of infertility, and it is the leading
reproductive disorder in many species, including women [1]
and cattle [2]. Thus, to increase female fertility, it is important
to understand the factors that influence ovulation, follicular
development, and atresia, which can contribute to anovulation. Ovulatory disorders due to endocrine hormone excess
or reduction account for 25% of infertility experienced by
couples [3]. Specifically, androgen excess can cause dysregulation of the hypothalamus–pituitary–gonadal axis and can
alter gonadotropin secretion to promote greater LH to FSH
ratios as seen in some women diagnosed with polycystic ovary
syndrome (PCOS) [4, 5].
The PCOS is a common anovulatory androgen excess
reproductive disorder affecting 5–7% of women of reproductive age [6, 7]. Women are diagnosed with PCOS if they
meet two of the three criteria: (1) hyperandrogenism, (2)
polycystic ovaries, and/or (3) anovulation [8]. In addition
to these criteria, PCOS women also have arrested follicle
growth and are predisposed to metabolic disorders such as
type II diabetes [9]. To understand the etiology of PCOS,
several non-human models have been created. These include
androgenized rats, which had fewer estrous cycles and
lower numbers of mature and ovulated follicles [10]. Sheep
treated with testosterone, early to mid-gestation, displayed
ovarian, hormonal, and metabolic characteristics of PCOS
[11]. Studies with mice [12], cows [13], and primates
[14] suggest that androgens promote the growth of preantral follicles and, in moderation, are critical to follicle
development.
Our laboratory has previously identified a naturally occurring androgen excess model [High A4] population of cows
within our research herd [15]. Previous reports from our
laboratory characterized the similarities between these High
A4 cows and women with PCOS [15] with increased mRNA
abundance of Luteinizing hormone Choronic Gonadotropin
receptor (LHCGR), Cytochrome P450 Family 11 Subfamily
A Member 1 (CYP11A1), Cytochrome P450 Family 17 Subfamily A Member 1 (CYP17A1), and GATA binding protein
6 (GATA6) in the theca cells, which were findings similar to
the expression patterns reported in PCOS women [16]. These
High A4 cows have intrafollicular A4 excess, follicular arrest,
and are often anovulatory with reduced fertility [15]. Furthermore, granulosa cell gene expression in High A4 cows compared to controls had reductions in cell cycle regulation genes,

indicating reduced proliferation and arrest of the cell cycle
[17]. Increased expression of CYP17A1 was also present in
High A4 granulosa cells, presumably, due to reduced Fos
proto-oncogene (FOS) mRNA [18], which has been shown
to allow for expression of CYP17A1 in granulosa cells previously. Culture of primary granulosa cells, in our lab, with
increasing concentrations of A4 also recapitulated these characteristics of High A4 cows with reduced proliferation and
increased secretion of anti-Mullerian hormone (AMH) [17].
Thus, High A4 cows are a naturally occurring androgen excess
domestic livestock model that has similar characteristics to
PCOS. [15]. Furthermore, the cow is an excellent model
for women; since, both have similar sized ovaries, follicular
waves resulting in a single ovulation, similar length luteal
phase, endocrine profiles, and gestation length [19]. Thus, our
naturally occurring High A4 cow model is an excellent model
to unravel the mechanisms contributing to anovulation and
female infertility.
Previously, we demonstrated that treatment with vascular
endothelial growth factor A (VEGFA) angiogenic isoform
(VEGFA165) in bovine cortex cultures induces more growing follicles [20, 21], while VEGFA antiangiogenic isoforms
(VEGFA165b) cause follicular arrest [20]. The signal transduction pathways that are activated through each of these
isoforms alone, VEGFA165 or VEGFA165b, or in combination have also been identified [20]. The KDR receptor can be
activated through VEGFA165 angiogenic isoform to stimulate
cell proliferation through Mitogen-Activated Protein Kinase
1 (MAPK) and Protein Kinase C (PKC) as well as cell migration through Rho Associated Coiled-Coil Containing Protein
Kinase 1 (ROCK) and ACT1 and cell proliferation and cell
survival through Phosphoinositol 3-kinase (PI3K). However,
VEGFA165b inhibits these pathways, and VEGFA165b in
combination with VEGFA165 results in neither inhibition nor
expression of these pathways, suggesting VEGFA165b can
inhibit VEGFA165’s angiogenic actions [20].
Other experiments within our laboratory utilizing rat ovarian organ cultures treated with an angiogenic isoform of
VEGFA (VEGFA165) resulted in fewer early stage follicles
(primordial follicles) and more follicles that developed to
later stages, suggesting that VEGFA165 stimulated follicular
progression [22]. However, when they treated the ovaries with
VEGFAxxxb antibody, which binds to antiangiogenic VEGFA
isoforms, there was greater follicle progression compared to
controls [22]. Similarly, treatment of bovine ovarian cortex
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with VEGFA165 [21] increased primordial follicle activation and formation of secondary follicles (3- to 4-fold) over
10 days in culture. Therefore, the presence of exogenous
VEGFA165 in the culture medium might have increased theca
and granulosa cell proliferation, resulting in the development
of larger follicles and follicular progression.
Therefore, the objective of the current study was to determine potential mechanisms of follicular arrest in High A4
cows and how excess A4 production by the ovarian microenvironment may be affecting follicular development. Furthermore, we sought to determine how VEGFA isoforms may
affect follicular development and progression. We hypothesized that ovarian steroidogenic microenvironment is a critical
mediator of follicle arrest and follicular fate in cows.

Materials and methods
All procedures were approved by the Animal Care and Use
Committee at the University of Nebraska-Lincoln. The University of Nebraska-Lincoln is AAA-LAC-certified.

Animals
Non-lactating, composite beef cows [25% MARC III (1/4
Angus, 1/4 Hereford, 1/4 Pinzgauer, and 1/4 Red Poll) and
75% Red Angus] from the beef physiology herd located at
the University of Nebraska Eastern Nebraska Research and
Extension Center was used in this study.
Classiﬁcations of cows into High A4 and control groups
Thirty cows were randomly selected from the physiology
herd, and estrous cycles were synchronized by two injections
of PGF2α (PGF2α , 25 mg/mL; i.m.; Lutalyse, Zoetis Animal
Health, Parsippany, NJ) 14 days apart (Figure 1A) to stimulate
progesterone removal with corpus luteum (CL) lysis. At 6–
56 h after the second PGF2α injection, the dominant follicles
were aspirated and the cows were classified according to
the androstenedione (A4) concentration in the follicular fluid
into control (A4 < 20 ng/mL) and High A4 (A4 > 40 ng/mL)
[15]. In the current manuscript, we have conducted two
trials; the first investigates the different steroid and paracrine
factors that are secreted by the control and High A4 cows
in vitro bovine cortex cultures. Because we were examining
the steroid ovarian microenvironment, we wanted to ensure
a natural estrous cycle without addition of steroids to determine differences that may occur in our High A4 and control
cows. In the second trial, we were treating both control and
High A4 with VEGFA angiogenic (VEGFA165) and antiangiogenic (VEGFA165b) isoforms alone and in combination
to determine if any of these VEGFA isoforms would rescue
factors contributing to follicle arrest in High A4 bovine cortex
cultures. Because the steroidogenesis in the dominant follicle
may be critical to the starting material in each bovine ovary,
we decided to use a progestin to synchronize the dominant
follicle to ensure similar steroidogenic profiles. As seen in the
data, there were no differences whether we used the synchronization regime in trials 1 or 2 since High A4 cows had similar
inflammatory and steroidogenic characteristics in each trial.
Trial 1
After classification, 20 cows (n = 9 High A4, n = 11 control)
were synchronized by lysing the CL with two injections of
PGF2α (25 mg/mL; i.m.; Lutalyse, Zoetis Animal Health,
Parsippany, NJ) 14 days apart (Figure 1B). Ovariectomy
was performed 36–42 h after the second PGF2α injection

(Figure 1B) and the ovaries were removed to collect ovarian
cortex for tissue culture 1C-G, (Figure 2A-H).
Trial 2
To determine if VEGFA isoforms would rescue the High
A4 phenotype, cows were synchronized with a progestin
[controlled internal drug release device (CIDR)] since this
synchronization method allows for better synchronization
of dominant follicle to similar stages and allows for ovaries
to be exposed to similar steroids from the dominant follicle.
The estrous cycles of 10 cows (n = 5 High A4, n = 5 control)
were synchronized with the Co-Synch + CIDR timed
artificial insemination (AI) protocol, except ovariectomy
was performed after synchronization rather than timed AI
[17] (Figure 3A). Briefly, cows received a single injection
(100 μg/cow; i.m.) of gonadotropin-releasing hormone
(Cystorelin, Merial Limited, Duluth, GA) on treatment day
0 to induce ovulation, and thus, initiate a new follicular
wave. Also, on day 0, an intravaginal insert (CIDR; Zoetis,
Florham Park, NJ) containing 1.38 g of P4 was inserted.
Ovariectomy (n = 10) was performed approximately 36–42 h
after CIDR removal, which coincided with the administration
of PGF2α to eliminate a functional CL (Figure 3A) and ovaries
were removed to determine ovarian cortex characteristics
(Figure 3B-G). Similar results were observed regardless of the
synchronization method that was used in these trials.

Ovarian tissue collection
In both trials, ovaries were removed using a right flank
laparotomy using aseptic technique [15, 23]. Local anesthesia
was induced using an inverted L-block with 2% lidocaine.
Each ovary was measured, weighed, and a count of surface
antral follicles was performed. Ovarian characteristics are in
Table 1 and 2 for trial 1 and 2, respectively.
Culture of ovarian cortical pieces
Ovarian cortical pieces were collected from each ovary from
each cow to determine the differences in folliculogenesis based
on cow A4 classification within follicular fluid [15, 20, 24].
Trial 1
An in vitro cortex culture was conducted with no treatment
(PBS) as published [24]. Portions of the ovarian cortex were
cut into eight ovarian cortex pieces of 0.5–1 mm3 per ovary.
Four ovarian cortical pieces per ovary were fixed immediately
in Bouin’s solution overnight at 4◦ C as day 0 (uncultured).
The other four cortical pieces were placed on uncoated culture well inserts (four pieces/well; one well/treatment/ovary/cow; Millicell-CM, 0.4 μm pore size; Millipore Corporation,
MA) in the wells of 24-well Costar culture plates (Corning,
Inc., Corning, NY) with 350 μL serum-free Waymouth’s
medium MB 752/1 (Sigma-Aldrich, St. Louis, MO) and supplemented with 75 μg/mL penicillin, 50 μg/mL streptomycin
sulfate (Sigma), and ITS [1000 mg insulin, 550 mg transferrin,
6.7 ng selenious acid (Corning; Manassas, VA)], 1.25 mg BSA
(Sigma), and 50 ng/mL PBS as stated previously [20, 24].
Trial 2
The cortical cultures were treated with different VEGFA
isoforms to determine effects on follicular development. The
bovine ovarian cortex culture method is published in more
detail in Sutton et al. [24]. The ovarian cortex pieces were
cut into 20 ovarian cortex pieces with 0.5–1 mm3 for each
piece. Four ovarian cortical pieces were fixed immediately
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Figure 1. Demonstrates the synchronization protocol (A) to obtain follicular ﬂuid through dominant follicle aspiration to classify the cows into High A4 or
control groups for all trials; (B) synchronization of estrous cycles prior to ovariectomy to obtain ovarian cortex pieces to culture for trial 1; (C) the average
number of follicles per ﬁelds at different follicle stages in control and High A4 cows before culture; (D) the average number of follicles for each stage and
per ﬁeld after 7 days of ovarian cortex culture; (E) representative H and E staining for control and High A4 cows, demonstrating follicle stages present in
each cow classiﬁcation; (F) the concentrations of A4 daily during the 7 day ovarian cortex culture for each cow classiﬁcation; and (G) the total amount of
A4 that was collected for all 7 days during the ovarian cortex culture in control and High A4 cows. Control (n = 11); High A4 (n = 9); difference is shown
between bars with ∗ P < 0.05; ∗∗ P < 0.01.

in Bouin’s overnight at 4◦ C as day 0 (uncultured). We used
the same protocol in trial 1 for trial 2 for cortex culture as
mentioned above, except that, instead of just PBS, each well
was treated with one of the following treatment: (1) PBS,
(2) VEGFA165 (50 ng/mL), (3) VEGFA165b (50 ng/mL), or
(4) VEGFA165 + VEGFA165b (50 ng/mL each) per ovary/cow with 10 replicates per treatment one for each ovary on
each cow.
In both trials, cortical pieces were cultured at 37◦ C in a
humidified incubator with 5% CO2 , and 70% of 350 μL
of culture medium was replaced (240–250 μL) with fresh
medium every day. After 7 days of culture in both trials, the
four ovarian cortical pieces were fixed immediately in Bouin’s
overnight at 4◦ C as day 7 (cultured) [25]. After that, day 0 and
day 7 cortical pieces were embedded in paraffin. Serial sections of 6 μm were cut into 10 slides using a microtome, and
five serial sections were mounted on each gelatin-coated slide.
Sections from slides 1, 5, and 10 were selected from each ovary
per each cow, which were stained with hematoxylin and eosin.
We took three images per slide for a total of nine images per
ovary, and follicles were staged and counted by three individuals and were averaged to determine the number of follicles
at each stage classified in one of five groups: (0) primordial
follicle—an oocyte surround by a single layer of squamous
pregranulosa cells; (1) transitional follicle or early primary—
an oocyte surrounded by mostly squamous pregranulosa cells
with some cuboidal granulosa cells; (2) primary follicle—an
oocyte surround by 1–1.5 layers of cuboidal granulosa cells;
(3) secondary follicle—an oocyte surrounded by two or more
cuboidal granulosa cells; and (4) antral follicle with an oocyte
surrounded by two or more layers of granulosa cells that

contains a distinct antrum [15, 25, 26]. From our imaging and
counting, we counted approximately 30% of follicles in each
ovarian cortex per ovary as published previously [20, 24].

Androstenedione hormone assay
To evaluate the level of androstenedione (A4) based on
cow A4 classification, we measured daily the concentration
of A4 in culture media in trial 1 and in trial 2 using
Immuchem™ Double Antibody, Androstenedione 125 I RIA
Kit (MP Diagnostics). Briefly, culture media was diluted 1:5
by using 100 μL of culture media and 400 μL of steroid
diluent. Following this step, the samples were assayed by
direct competitive binding determination. Samples values
were corrected for dilution factor [15]. Intra- and inter-assay
CVs for A4 in trial 1 were 6.18% and 4.48%, respectively, and
the intra- and inter-assay CVs for A4 in trial 2 were 7.37%
and 4.59%, respectively.
In trial 2, in order to analyze the concentration of multiple steroid hormones from a single sample, a pool from
first 5 days of culture media that were treated with PBS,
VEGFA165, VEGFA165b, and VEGFA165 plus VEGFA165b
were analyzed by Biocrates Life Sciences AG (Innsbruck,
Austria) using the SterolDQ HPLC-MS/MS kit as previously
reported [15, 24, 27].

Picro-Sirius Red staining
Picro-Sirius Red (PSR) is a stain used for histological visualization of collagen I and III fibers (as an indicator of
fibrosis) [24]. The PSR staining was conducted in both trials
as published previously [24, 28]. Briefly, tissue sections were
deparaffinized in xylene and then rehydrated in a series of
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Figure 2. Collagen staining (PSR) for (A) control and (B) High A4 ovarian cortex cultures. (C) Graph comparing the average area of PSR-positive staining
per ovarian cortex ﬁeld (pixels/μm2) between High A4 and control cows; control (n = 11), High A4 (n = 9). (D–H) Immunoﬂuorescent staining for oxidative
stress (4-HNE) negative controls for (D) control and (E) High A4 cow (4-HNE) and (F) controls. (G) High A4 cow ovarian cortex and (H) graph quantitating
the integrated intensity of 4-HNE-positive staining per ovarian cortex ﬁeld (arbitrary units) between High A4 and control cows. ∗ P < 0.05.

graded ethanol baths (100%, 70%, and 30%). Tissue sections
were immersed for 1 h at room temperature in a PSR staining
solution prepared by dissolving Sirius Red in picric acid
(Direct Red 80, Sigma). Tissues were washed 3 × 5 min in
0.5% glacial acetic acid in water. Excess acidified water was
carefully wicked away from the tissue sections, and the tissue
was rapidly dehydrated in 100% ethanol (a total of three,
1-min incubations each). The tissues were cleared in xylene
for 5 min and were mounted with Permount mounting media
(SP15-100 Toluene Solution; Fisher Scientific). To quantify
the area of ovarian tissue that was positive for PSR staining,
we followed the protocol as described in [25, 28] using cows
of the same age. Two images were taken from different field
using a 40X objective. ImageJ was used to quantify the area of
positive PSR staining above a threshold that was set based on
the staining in the Control cows. This threshold was constant
for all images analyzed. This procedure from our laboratory
is published [25].

Immunoﬂuorescence staining
For immunofluorescence (IF) for 4-hydroxynonenal (4-HNE;
oxidative stress marker), we used representative ovarian cortex pieces in both trials fixed in Bouin’s solution, embedded
in paraffin, and sectioned (6 μm) into gelatin-coated slides
with five serial sections on each slide, four cortex pieces per
serial section. The IF was performed as previously described
[20, 29]. The 4-HNE antibody (catalog no. ab46545; abcam)
was a rabbit polyclonal primary antibody. We used donkey

anti-rabbit secondary antibody (Alexa Fluor 488; catalog
no. ab150061; abcam). The primary antibody was diluted
1:100 and the secondary antibody was diluted 1:500 in 10%
normal donkey serum. For a negative control, one or two
sections were processed without primary antibody. ImageJ, as
published previously [24], was used to quantify the area of
positive 4-HNE staining.

Quantibody cytokine array
Because of reports of inflammatory cytokines being involved
in fibrosis [25], ovarian cortex culture media from the first
5 days of culture in control and High A4 cows were pooled
from trial 1. The samples were analyzed with commercially
available antibody arrays (Table 3; Quantibody Cytokine
Q3 and Q1 Arrays, RayBiotech, GA, USA) [24] measuring
20 different cytokines and chemokines in the pro- or antiinflammatory pathway: angiopoietin 1 (ANG1), CD40
ligand, chemokine (C-C motif) ligand 4 (CCL4, also known as
macrophage inflammatory protein-1β (MIP-1β)], chemokine
(C-C motif) ligand 5 (CCL5, also known as RANTES—
regulated on activation, normal T cell expressed and secreted),
chemokine (C-X-C motif) ligand 9 (CXCL9, also known
as MIG—macrophage interferon gamma), C-X-C motif
chemokine ligand 10 (CXCL10, also known as Interferon
gamma induced protein, IP-10), decorin, interferon beta 1
(IFNβ), interferon gamma (IFNγ ), interleukin-18 (IL18),
leukemia inhibitory factory (LIF), interleukin 13 (IL13),
interleukin 21 (IL21), interleukin 36 receptor antagonist
(IL36RA, also known as IL1F5—interleukin 1 family member
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5), tumor necrosis factor alpha (TNFα), interferon alpha A,
interleukin 10 (IL-10), interleukin 17 alpha (also known as
cytotoxic T-lymphocyte-associated protein 8), which have
been validated for bovine samples [30, 31]. Cortex culture
samples were assayed without any dilution. Array slides
were shipped back to the company for data extraction and
retrieval. Data were received from Raybiotech and were
analyzed with their analysis program. The same procedure
was followed in trial 2, except, the samples were treated with
PBS (control), VEGFA165, VEGFA165b, or a combination
as stated previously. Results of the cytokine and chemokine
arrays demonstrated that several were reduced by VEGFA
isoform treatments (Figure 7B–D).
AMH ELISA
Media from bovine cortex cultures were measured for AMH
from samples combined from trials 1 and 2 by utilizing a
commercially available bovine AMH ELISA kit (Ansh Labs,
Webster, TX, Ca# AL-114) validated in cattle [32–34] and
used by us previously [17]. For the analysis, culture media was
not diluted and the manufacture’s protocol was followed. The
intra-assay CV was 1.96%.
Statistical analyses
In both trials, the average length, width, and surface antral
follicle count (AFC) were compared using the MIXED procedure of SAS with group as the fixed effect. Animals were
considered the experimental unit in both trials. All data are
presented as means ± SEM and a P-value < 0.05 was used
as threshold for significance and a P-value of 0.05–0.10 was
used as a tendency for all analyses.
Trial 1
The histological evaluations of primordial, primary, secondary, and antral follicles were analyzed using the MIXED
procedure of SAS with A4 classification groups (High or
control) as a fixed effect. Culture media collection data were
analyzed using the MIXED procedure of SAS with days of
culture, in vivo treatments, and the interactions as fixed
effects in a repeated measures model. Cortex culture media
cytokines and chemokines collection data were analyzed using
the MIXED procedure of SAS with in vivo treatments as fixed
effects. Correlation was calculated using CORR procedure
of SAS between the amounts of A4 produced in the culture
media and the area that stained positively for fibrosis.
Trial 2
The A4 classification groups (High A4 or control) and in
vitro culture treatments (PBS, VEGFA165, VEGFA165b, and
VEGFA165 plus VEGFA165b) were used as fixed effects.
The fold changes were calculated for each treatment after
culture by dividing the number of follicles after in vitro culture
over number of follicles before culture within stage. Follicle
numbers to which comparisons were made were set as a
minimum value of one to avoid dividing by zero, and then
we analyzed the change in primordial, primary, secondary,
and antral follicles after culture using the PROC GLIMMIX
procedure of SAS. The interaction between in vivo and in vitro
treatments was significant for some of follicles stages, and the
interaction between in vivo and in vitro treatments will be
discussed. Culture media collection data were analyzed using
the MIXED procedure of SAS with days of culture, in vitro
treatments, in vivo treatments, and the interactions as fixed

effects in a repeated measures model. Cortex culture media
cytokines and AMH collection data were analyzed using the
MIXED procedure of SAS with in vivo treatments as fixed
effects.

Results
Trial 1
Phenotype measurements
There were no differences in ovarian area, ovarian weight, and
surface AFC based on A4 classification as demonstrated in
Table 1.
Follicle stage in ovarian cortex cultures
The number of follicles classified primordial, early primary,
primary, secondary, and antral in control ovaries were compared to High A4 ovaries. Before culture, ovarian cortex
pieces from High A4 ovaries had more (P = 0.005) primordial
follicles (2.42-fold; stage 0) compared to the cortex pieces
from the control ovaries (Figure 1C). There was no difference
(P = 0.336) in the number of early primary follicles (stage 1)
(Figure 1C) between ovarian cortex of control and High A4
cows. However, ovarian cortex from control cows had more
follicles classified as primary (4-fold; P = 0.001), secondary
(4-fold; P = 0.001), and antral (5-fold; P = 0.048) (stages 2–
4, Figure 1C) compared to ovarian cortex of High A4 cows.
Conversely, the cortex pieces from High A4 ovaries had
more (P = 0.009) primordial follicles (2.9-fold; stage 0) compared to the cortex pieces from control ovaries (Figure 1D)
after 7 days of culture. After culture, there was no difference (P = 0.199) in the number of early primary (stage 1,
Figure 1D) between the ovarian cortex of control and High
A4 cows. Additionally, ovarian cortex from the control had
more follicles classified as primary (P = 0.002), secondary
(P = 0.003), and antral (P = 0.014) (stages 2–4, Figure 1D)
compared to the ovarian cortex from High A4 cows after
culture.
Steroids’ concentrations in the culture media
There was no significant difference (P = 0.333, Figure 1E) for
the interaction between our groups (High A4 vs. control cows)
and days of culture (D1–D7). However, the ovarian cortex
from High A4 cows secreted greater (43X) amounts of A4
(P = 0.007; Figure 1E and F) compared to control cows.
Markers of inﬂammation
Fibrosis
There was increased positive staining for a collagen marker
(PSR, an indicator of fibrosis) in High A4 compared to control
ovarian cortex pieces (Figure 2A and B). Ovarian cortex from
the High A4 cows had nearly 63-fold the amount of PSRpositive collagen staining in the ovarian cortex and stroma relative to the control cows (P = 0.05; Figure 2C). Additionally,
there was a positive correlation (P = 0.02; R = 0.51) between
the amount of A4 produced by the ovarian cortex and the area
that stained for fibrosis in the High A4 cows.
Oxidative stress
There was increased positive staining for the oxidative
stress marker, 4-HNE, in the ovarian cortex and ovarian
stroma of High A4 cows compared with the control cows
(Figure 2D–G). Ovarian cortex from the High A4 cows had
nearly 11-fold the amount of integrated intensity of 4-HNE
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Table 1. Ovarian area, weight, and surface AFC in control and High A4 cows at ovariectomy in trial 1

Ovarian area, mm2
Ovarian weight, g
Surface AFC
1 Dominant

Control1 N = 11
589.75 ± 73.59
7.60 ± 0.88
33.91 ± 3.55

follicle follicular fluid A4 concentration of <20 ng/mL.

High A42 N = 9
706.27 ± 81.36
9.08 ± 0.97
29.22 ± 3.92
2 Dominant

P-value
0.30
0.28
0.39

follicle follicular fluid A4 concentration of >40 ng/mL.

Table 2. Ovarian area, weight, and surface AFC in control and High A4 cows at ovariectomy in trial 2

Ovarian area, mm2
Ovarian weight, g
Surface AFC
1 Dominant

Control1 N = 5
768.44 ± 70.05
9.92 ± 0.88
31.20 ± 3.64

follicle follicular fluid A4 concentration of <20 ng/mL.

High A42 N = 5
777.87 ± 70.05
10.40 ± 0.88
28.00 ± 3.64
2 Dominant

staining in the ovarian cortex and stroma relative to the
control cows (P = 0.03; Figure 2H).
Cytokines and chemokines
Twenty different cytokines and/or chemokines that were
either pro-inflammatory or anti-inflammatory or considered
both were analyzed in cortex culture media in trial 1 (Table 3).
High A4 ovarian cortex culture media had increased concentrations of INFα (P < 0.01), IL13 (P < 0.01), and TNFαα
(P < 0.001) with a tendency for increased CXCL10/IP10
(P < 0.07) and INF-γ (P < 0.1) compared to controls.

Trial 2
Phenotype measurements
There were no differences in ovarian area (P = 0.93), ovarian
weight (P = 0.71), and surface AFC (P = 0.55) based on A4
classification (Table 2).
Follicle stage in ovarian cortex cultures
There were greater numbers of follicles classified as primary,
secondary, and antral in the control ovarian cortex compared
to High A4 before culture (Figure 3B). While, cortex pieces
from High A4 ovaries contained greater numbers of follicles
classified as primordial follicles (P = 0.004; Figure 3B) prior
to culture with fewer numbers of follicles classified as primary
(P = 0.01; Figure 3B), secondary (P = 0.0001; Figure 3B), and
antral (P = 0.008; Figure 3B) compared to control ovarian
cortex before culture. There was no difference (P = 0.48) in
the number of early primary (stage 1) (Figure 3B) between the
ovarian cortex of control and High A4 cows before culture.
None of the in vitro treatments during culture altered the
number of primordial follicles between ovarian cortex of
High A4 and Control cows (Figure 3C). The ovarian cortex
treated with VEGFA165 in High A4 and control cows had
the greatest increase in numbers of early primary follicles
(P = 0.05; Figure 3D), with reductions in the number of early
primary follicles treated with VEGFA165b or combination
compared to VEGFA165.
Numbers of primary follicles (Figure 3E) were not changed
due to treatment in either control or High A4 ovarian cortex
cultures.. However, numbers of secondary follicles were
greater in controls compared to High A4 ovarian cortex (PBS).
The VEGFA165 treatment increased secondary follicles in
both control and High A4 classifications compared to PBS
treatment; but, secondary follicles numbers were still greater

P-value
0.93
0.71
0.55

follicle follicular fluid A4 concentration of >40 ng/mL.

in controls compared to High A4 ovarian cortex (Figure 3F).
There also were reductions in numbers of secondary follicles
in VEGFA165b and combination treatments when compared
to VEGFA165-treated ovarian cortex (Figure 3F). Similarly,
antral follicle numbers were greater in VEGFA165-treated
ovarian cortex when compared to PBS or VEGFA165b
or combination treatment regardless of cow classification
(Figure 3G). Thus, VEGFA165 treatment can stimulate
increased follicles at the early primary, secondary, and antral
follicles stage and can increase these follicle stages in High A4
cows so they are not different from controls. Furthermore,
the VEGFA165b and combination treatment indicate that
VEGFA165b can inhibit the actions of VEGFA165 angiogenic
isoforms and can reduce the number of follicles to these later
stages of development.
Steroids’ concentrations in the culture media
There was a significant difference (P = 0.001; Figure 4A)
between our experimental groups (High A4 vs. control), in
vitro culture treatment (PBS, VEGFA165, VEGFA165b, and
VEGFA165 plus VEGFA165b), and days of culture (D1–
D7). Ovarian cortex from High A4 cows that were treated
with PBS, VEGFA165b, and VEGFA165 plus VEGFA165b
secreted the greatest amounts of A4 (Figure 4A and B) in
the culture media compared with control cows. By contrast,
treatment with VEGFA165 significantly reduced (4.2 times;
P = 0.001) the amount of A4 secreted by the ovarian cortex
of High A4 cows treated with PBS, and this was also
reduced from VEGFA165b or combination isoform treatment
(Figure 4A and B).
The concentrations of A4 and other steroids and steroid
metabolites in the culture media, including 11-deoxycortisol,
17-OHP, androstenedione, were greater, while E2 and androsterone tended to be greater in High A4 cows compared to
controls (PBS; Figure 4C and D). The VEGFA165 treatment
in all of the previously mentioned steroid hormones reduced
concentrations of steroids to the levels of the control cows
(PBS). However, VEGFA165b and the combination treatment
did not reduce steroid production. In fact, both VEGFA165b
and the combination treatment increased progesterone production in ovarian cortex cultures from High A4 cows compared to controls. Thus, the VEGFA165 treatment rescued
much of the steroid excess that was present in the ovarian
cortex cultures of High A4 cows, while VEGFA165b and
the combination of VEGFA165 plus VEGFA165b stimulated
increased progesterone production (Figure 4C).
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Figure 3. Synchronization of estrous cycles of cows in trial 2 (A) and graphs of follicular counts at each follicular stage for High A4 and control cows
(control, n = 5; High A4, n = 5) (B) before culture all stages; and (C–G) after culture in trial 2 treated with different VEGFA isoforms; (C) primordial; (D)
early primary; (E) primary; (F) secondary; and (G) antral follicles. Differences are denoted by ∗∗ P < 0.01; ∗ P < 0.05; ns = not signiﬁcant.

Figure 4. Concentrations of steroids secreted into ovarian cortex media in trial 2 for High A4 and control cows with different in vitro treatment (A) over
each day of the culture period and (B) average of 7 days in culture. (C) HPLC-MS analysis for different steroid hormones and metabolites secreted from
PBS, VEGFA165, VEGFA165B, and combination-treated cortex culture media for control and High A4 cows. (D) Schematic of increased steroid in ovarian
cortex of High A4 cows. Statistical differences are denoted by ∗ P < 0.05; +P < 0.07; n for control = 5; n for High A4 = 5; ns = not signiﬁcant.
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Figure 5. (A) Collagen staining (PSR) for High A4 and control ovarian cortexes before culture and after culture with different VEGFA isoforms in trial 2; (B)
graph comparing the average area of PSR-positive staining per ovarian cortex ﬁeld (pixels/μm2 ) between High and control cows before culture and after
culture with different VEGFA isoforms. Statistical differences are denoted with ∗∗ P < 0.01 or ns P > 0.10. n for control = 5; n for High A4 = 5.

Markers of inﬂammation
Fibrosis
There was increased positive staining for a collagen marker
(PSR, an indicator of fibrosis) in High A4 ovarian cortex
compared to control ovarian cortex pieces before culture (D0;
P = 0.001; Figure 5A and B). Treatment with VEGFA165
dramatically (P = 0.001) reduced the staining of collagen
(Figure 5A and B) compared with VEGFA165b and combination of VEGFA165 plus VEGFA165b after 7 days of culture.
Oxidative stress
There was increased positive staining for the oxidative
stress marker (4-HNE) in the ovarian cortex of High
A4 compared with the control cows (Figure 6A–M). The
interaction between in vivo and in vitro treatments (level of
A4 and VEGFA isoforms) was not statistically significant.
When in vitro treatments had an effect, the main effect
was discussed. Ovarian cortex from the High A4 cows
had an increased integrated intensity of 4-HNE staining in
the ovarian cortex relative to the control cows (P = 0.02;
(Figure 6M). Positive staining for 4-HNE was present
in oocytes, granulosa, and stroma cells. Treatment with
VEGFA165 dramatically (P = 0.05) reduced the staining
of the oxidative stress (Figure 6N) compared with PBS,
VEGFA165b, and VEGFA165 plus VEGFA165b treatments.
While VEGFA165b did not reduce the staining of the
oxidative stress in ovarian cortex from the High A4 cows

compared to control cows. Moreover, VEGFA165b had
a higher staining of the oxidative stress compared to
VEGFA165 within the ovarian cortex of High A4 cows.
Cytokines and chemokines
Twenty different cytokines and/or chemokines that were
either pro-inflammatory or anti-inflammatory (or considered
both) were analyzed in cortex culture media in trial 2, and
the effects of VEGFA isoforms were evaluated to determine
how they impacted the cytokines and chemokines that were
increased in trial 1 (Table 3). The same cytokines were
elevated as in Table 3; however, only three were affected by all
VEGFA isoform treatments such that INFα (P < 0.01) and IL13 (P = 0.03) were reduced by all VEGFA isoform treatments
compared to PBS and INFγ tended (P < 0.06) to be reduced
(Figure 7A–C). Thus, all isoforms of VEGFA can reduce these
three cytokines/chemokines to concentrations found in the
control ovarian cortex culture media.
Concentration of AMH in ovarian cortex culture media
from trials 1 and 2
Ovarian cortex media from both trials 1 and 2 were pooled
from D1–D5 for individual cows and were used to analyze AMH production in media from ovarian cortex culture
between control and High A4 cows. The concentration of
AMH was greater in High A4 ovarian cortex media (P < 0.03)
compared to controls (Figure 7D), indicating that increased
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Figure 6. (A–L) Immunoﬂuorescent staining for oxidative stress (4-HNE) negative controls for (A) control and (B) High A4 cows; before culture (C)
controls and (D) High A4 cows; after culture with PBS (E) control and (F) High A4 cow; after culture with VEGFA165 (G) control and (H) High A4 cow;
after culture with VEGFA165b (I) control and (J) High A4 cow; after culture with combination (K) control and (L) High A4 cow ovarian cortex. (M) Graph
comparing the integrated intensity of 4-HNE-positive staining per ovarian cortex ﬁeld (arbitrary units) between High and control cows; (N) graph
quantitating the integrated intensity of 4-HNE-positive staining per ovarian cortex ﬁeld (arbitrary units) between different in vitro culture treatments.
Statistical differences are denoted by ∗ P < 0.05. n for control = 5; n for High A4 = 5.

Figure 7. Effects of VEGFA isoforms on cytokines and chemokines in ovarian cortex culture media. Graphs representing PBS, VEGFA165, VEGFA165b,
and combination treatments for (A) INFα, (B) IL-13, and (C) INFγ . (D) Concentrations of AMH in ovarian cortex cultures in trials 1 and 2. Control, n = 16,
white bars; High A4, n = 14, black bars. Statistical differences are denoted on the graphs where P < 0.05 are different and P > 0.05 but <0.1 tend to be
different.
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Table 3. Concentrations of cytokines and chemokines in the cortex culture media in control and High A4 in trial 1

Group
Control
11

High A4
9

SEM

P-value

n
Cytokine/chemokine, pg/mL
ANG-1
CD40 ligand
CCL4/MIP-1β
CCL5/RANTES
CXCL9
CXCL10
Decorin
INF-α
INF-β1
INF-γ
IL-1α
IL-1β
IL-10
IL-13
IL-17A
IL-18
IL-21
IL36RA/IL-1F5
TNFα
LIF

56.03
3624.31
371.74
2198.06
0.16
1121.92
2104.51
104.81
544.81
7.40
30.56
18.93
13 399
5.34
54.19
464.97
31.05
1.08
22.78
28 110

64.76
1103.59
616.61
2800.50
90.43
2179.34
2274.92
227.51
710.25
15.69
55.49
17.60
10 854
26.13
36.50
713.38
38.41
2.72
95.66
54 877

26.96
261.58
138.60
1058.11
45.45
378.69
383.00
30.58
167.25
3.21
10.26
9.15
5700.58
5.18
27.19
334.88
14.83
0.73
14.88
15 232

0.83
0.19
0.25
0.70
0.19
0.07†
0.77
∗∗
0.01
0.51
0.10†
0.12
0.92
0.76
∗∗
0.01
0.66
0.62
0.74
0.15
∗∗∗
0.001
0.25

∗

∗∗

∗∗∗

P-value <0.05. P-value <0.01.
P-value < 0.001. † P-value <0.10. MIG = monokine induced by gamma interferon, IFN-α = interferon alpha, IL-1α
= interleukin 1 alpha, IL-1β = interleukin 1 beta, IL-17A = Interleukin-17A.

concentrations of AMH may also contribute to follicular
arrest in the High A4 cow ovarian cortex.

Discussion
The results of the present study confirm our hypothesis
that the ovarian steroidogenic environment influences the
follicular development in the cow. The ovarian cortex in
the High A4 cows displayed follicular arrest and increased
markers of oxidative stress and fibrosis within increased
secretion of AMH and pro-inflammatory cyokines. Similarly,
women with PCOS are characterized to have excess ovarian
androgen production, abnormal follicle growth, increased
pro-inflammatory cytokines and AMH, anovulation, and
infertility [35]. As we observed in both trials before culture
(D0), High A4 cows had more primordial follicles compared
with our control cows. This increase in the number of
primordial follicles indicates that follicle activation is being
inhibited and does not necessarily suggest increased ovarian
reserve. According to recent research, collagen controls the
stiffness of the ovary [36], and an in vitro study found
that physically stiffer conditions allow for primordial follicle
survival and growth in nonhuman primates [37]. As a result,
the increased fibrotic and collagen-rich cortex in the ovaries
of High A4 cows may be retaining primordial follicles and
not allowing for the development of later stage follicles.
These High A4 cows also have sporadic ovulation and often
are anovulatory [38], indicating that this stiffer ovarian
structure and steroid excess microenvironment may inhibit
the development and ovulation of antral follicles necessary
for normal reproductive function.
The High A4 cows had fewer primary, secondary, and antral
follicles compared with the control cows, supporting our
previous report of reducing High A4 compared with control
cows [15]. Also other experiments [39] have demonstrated

that hyper-androgenism or abnormal androgen levels seriously suppress normal follicular development and increase
follicular atresia and degeneration in human and rhesus monkey females. Likewise, excess androgen is associated with
ovarian dysfunction in cattle [40] and with an increase in
cell cycle arrest, autophagy, and apoptosis in granulosa cells
[17]. Chen et al. [10] also reported that androgenized rats had
fewer estrous cycles and lower numbers of mature and ovulated follicles. These studies indicate that excess A4 disrupts
follicle growth and prevents follicle progression to primary,
secondary, and antral follicle stages.
Androgen production by the ovarian cortex in the High
A4 cows may be the factor causing altered ovarian morphology and leading to oxidative stress. Oxidative stress results
when there is an imbalance between pro-oxidant molecules
and antioxidant defense systems, which results in a buildup of reactive oxygen species (ROS); which is a common
characteristic of inflammatory processes [41–43]. Furthermore, the oxidation of unsaturated lipids by ROS can cause
excessive levels of lipid peroxidation followed by the generation of degradation products [42]. The resulting aldehyde
compounds are more toxic, such as malondialdehyde and
4-hydroxynonenal (4-HNE) [42]. Excessive ROS production
during follicle development and oocyte maturation may also
cause negative effects on the growth and development of
follicles and on oocyte competence [43]. Oxidative stress is
also a major contributor to the pathogenesis and development
of PCOS [32, 43]. Previous studies found that the excess
androgen in circulation is associated with increased oxidative
stress in women with or without PCOS [33]. The ROS is
also released in physiologic processes, such as ovulation and
regression of the CL [41, 42]. Thus, the increased A4 secreted
from the High A4 cow ovarian cortex may cause increased
ROS accumulation in the High A4 follicle, resulting in aberrant folliculogenesis.
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The bovine ovarian cortex is highly steroidogenic, producing many steroids and steroid metabolites. In the current study,
we demonstrated that, in addition to increased concentrations
of A4, we also observed elevated 11-deoxycorticosterone, 11deoxycortisol, 17-OHP, androsterone, A4, and E2 compared
to control cows. To our knowledge, this is the first study
to report steroid and steroid metabolites secreted from
the bovine ovarian cortex. These data support previous
results reported by Summers et al. [15] who found that 11dehydroxy-corticosterone and E2 were elevated in follicular
fluid of High A4 compared to control cows.
In addition to evidence of oxidative stress, we also found a
positive correlation between the amount of A4 produced by
the ovarian cortex and the area that stained for fibrosis in the
High A4 cows. Fibrosis occurs when the homeostasis between
synthesis and degradation of extracellular matrix components
is altered [28], and as fibrosis continues to develop, tissue
architecture and function are compromised. Women diagnosed with PCOS have an increase in the thickness of ovarian
stroma due to increased collagen deposition and development
of fibrous tissue [34] with an increase in protease activity
[44]. Protease activity disrupts the normal tissue remodeling
process, availability of different growth factors, and the communication through cellular gap junctions, contributing to
the abnormal ovarian phenotype associated with PCOS [44].
Follicle arrest observed in women with PCOS is also associated with increased collagen deposition and fibrosis along
with increased cytokine production leading to inflammation
in these women. Elevated circulating concentrations of TNFα
contribute to inflammation in PCOS patients and also may
influence the alterations in structure occurring at the level of
the ovary [35].
In general, when ovarian organ cultures or pieces of ovarian tissue are placed into culture, there is a spontaneous
development of follicles to later stages of development, with
the majority of follicles progressing past secondary follicles. Thus, it was unexpected in both trials with no treatment (PBS) that the ovarian cortex from High A4 cows
did not display increased follicle progression after 7 days of
culture. Given increased evidence of fibrosis and follicular
arrest, the High A4 cortex may be secreting factors from
the extracellular matrix which lead to fibrosis. High A4
ovarian cortex media had increased cytokines, IL-13, INFα,
and TNFα, and a tendency for increased CXCL10/IP-10 and
INFγ . Interleukin-13 has been shown to collaborate with
TNFα to cause fibrosis by inducing secretion of transforming
growth factor beta 1 (TGFβ−1), a known fibrosis inducing growth factor [25].Thus, increased A4 concentrations
may be increasing IL-13 along with other pro-inflammatory
cytokines to impair follicle growth and development.
Another ovarian cortex secreted factor AMH, a TGFβ family member, may also contribute to follicular arrest and fibrosis. We demonstrated previously that treatment of granulosa
primary cultures with increasing A4 concentrations increases
AMH [17]. We also observed greater concentrations of AMH
secreted in our High A4 bovine cortex media, indicating
that excess A4 may increase AMH, which can contribute to
reduced granulosa cell proliferation [17] and follicular arrest.
Therefore, additional studies are necessary to determine which
factor is the originator of this phenotype culminating in or
initiating follicle arrest.
Previous research from our laboratory has demonstrated that angiogenic VEGFA isoforms and VEGFA signal
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transduction inhibitors cause follicle progression in both
the bovine [20] and rat [29] model systems. However,
we have not previously used a model displaying follicular
arrest to test the VEGFA angiogenic isoform treatment. As
expected, angiogenic isoform, VEGFA165, increased follicular
progression to later stages of development by increasing the
number of early primary, primary, secondary, and antral
follicles in both High A4 and control cows. These results
agree with Yang and Fortune [21] who, in 2007, found
that VEGFA increased the number of secondary follicles in
bovine cortical pieces by 3- to 4-fold over 10 days in culture,
suggesting a role for VEGFA in preantral follicle growth in
cattle. Moreover, the addition of VEGFA165 to the culture
medium improved the development of goat preantral follicles
cultured in vitro, allowing the production of mature oocytes
[45]. In vivo, Danforth et al. [46] found a 75–100% increase
in the number of primary and secondary follicles after the
injection of VEGFA (within 24 h) into rat ovaries, suggesting
a role in regulating growth of early follicles.
Interestingly, in the current study, VEGFA165 not only
advanced follicle development, but it also reduced A4 and
other steroid hormones being secreted into the culture media
from High A4 ovarian cortex. Recently, Asadi et al. [47]
found an increase in the concentrations of 17β-estradiol after
6 days of treatment with VEGFA165 in human ovarian cortex
cultures. However, we found that VEGFA165 dramatically
reduced steroids and metabolites in culture media to the levels
of these steroids in the control cow ovarian cortex. We are
not sure of the specific mechanisms of this steroid reduction.
Yamashita et al. [48] reported that treatment with VEGFA165
modulated the expression of bovine placenta steroidogenesis
in vitro by increasing or decreasing P4 and estrone sulfate
(E1) concentrations as well as aromatase P450-positive cell
density, depending on gestational age of the fetus [49]. Our
samples were analyzed on a 16 steroid and metabolite panel
(see Materials and methods). It is possible that VEGFA165
increases aromatase activity to convert steroid precursors to
E2. The steroid and metabolite panel measured E1, and we
did not observe changes in our High A4 bovine cortex culture
media.
In addition to the reduction of steroids, VEGFA165 also
diminished fibrosis and oxidative stress in High A4 ovarian
cortex to the level of controls, indicating that this growth
factor may rescue the High A4 phenotype. This finding agrees
with Wang et al. [50] who found that the administration of
VEGF165 triggers angiogenesis and inhibits both apoptosis
and fibrosis. Asadi et al. [47] also demonstrated that, in
ovarian cortex cultures treated with VEGFA165, there was
an increase in secondary follicles with a reduction in atretic,
suggesting that VEGA165 promotes the proliferation and
viability of granulosa cells to allow for follicle progression.
These previous reports would support our previous research,
where we found that cultured bovine cortex with VEGFA165
stimulated the expression of genes related to cell cycle, cell
proliferation, and growth [20]. In the current study, bovine
cortex treated with the anti-angiogenic isoform VEGFA165b
or the combination of VEGFA165 plus VEGFA165b did not
reduce steroids, fibrosis, or oxidative stress in High A4 cows
compared to controls. Furthermore, VEGFA165b appears
to antagonize the actions of angiogenic isoform VEGFA165
neutralizing its actions when given in combination.
Interestingly, after VEGFA isoform treatment, three of the
cytokines that were elevated, IL-13, INFα, and INFγ , were
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reduced to control levels, suggesting that the VEGFA isoforms
are relieving inflammation and inhibiting cytokine production. This may be due to VEGFA’s ability to make tissues more
permeable as well as its ability to reduce fibrosis and oxidative
stress as demonstrated by our studies.
Havelock et al. [51] demonstrated the presence of all
enzymes necessary for androgen production in the postmenopausal ovarian stroma in women; however, there have
been no studies to demonstrate this in bovine stroma. The
excess A4 secreted into the media from ovarian cortex cultures
of High A4 cows may be due to the stroma cell production
of A4 or enhanced production of A4 by other cells within
the High A4 cow ovary or excess expression by these cells.
We have demonstrated [20] there is increased expression
of Cytochrome P450 Family 17 Subfamily A Member 1
(CYP17A1), a steroid enzyme that produces androgens, in
granulosa cells from High A4 cows. So it seems highly
plausible that other cell populations may have increased
expression of CYP17A1, producing androgen in greater
quantities than control cows. Also excess A4 may be due
to lack of activation of aromatase and reduced conversion of
androgens to estrogens.

Conclusion
As indicated in the graphical abstract, the ovarian cortex
from High A4 cows secretes greater concentrations of A4,
which may associated with increased fibrosis, oxidative stress,
AMH secretion, and increased secretion of pro-inflammatory
cytokines and chemokines, resulting in arrested follicle development. Stroma or other ovarian cells within the ovarian
cortex could be a primary source or contributing sources of
A4 in the High A4 cow population. Angiogenic VEGFA165
isoforms can reduce A4, other steroid hormones, rescue follicle development, oxidative stress, and fibrosis and selective
cytokine production. Thus, VEGFA165 may be used as a
potential therapeutic to restore the ovarian microenvironment
and to enhance follicular maturation. In conclusion, our High
A4 bovine cortical cultures provide an excellent in vitro
model to understand and unravel the mechanisms involved in
follicular arrest and ovarian steroid microenvironment effects
on follicle fate.
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